SCHEMBL3837565

SCHEMBL3837565

CCCc1cccc(C#Cc2cccc(-c3ccccc3)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGES O14684 6/20 0.46
GRM5 P41594 1/20 0.46
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
FFAR1 O14842 2/20 0.39
CYP2D6 P10635 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
DRD2 P14416 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
AGXT P21549 1/20 0.39
KIF11 P52732 1/20 0.38
KAT6A Q92794 1/20 0.38
ASIC3 Q9UHC3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3836802 0.90 PTGES (0.50) PTGESFFAR1CYP2D6HRH3DRD2
SCHEMBL28255391 0.89 FFAR1 (0.48) PTGESGRM5FFAR1ASIC3
SCHEMBL4533749 0.84 AGXT (0.52) CTSSCTSKHRH3AGXTKIF11
SCHEMBL10078136 0.82 AGXT (0.50) CTSSCTSKHRH3AGXTKIF11
SCHEMBL3841194 0.81 FFAR1 (0.44) PTGESFFAR1CYP2D6HRH3DRD2
SCHEMBL234830 0.81 MAOA (0.46) PTGESGRM5AGXTASIC3
SCHEMBL612967 0.81 PTGES (0.47) PTGESGRM5FFAR1CYP2D6HRH3
SCHEMBL3836772 0.80 AGXT (0.48) CTSSCTSKAGXTKIF11
SCHEMBL24005570 0.80 CTSS (0.50) CTSSCTSKAGXT
SCHEMBL3843357 0.79 GRM5 (0.48) PTGESGRM5FFAR1CYP2D6HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111223-A1 AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2009-10-28 EP disclosed
WO-2009058216-A1 AMINE DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2009-05-07 WO disclosed